Edwards Lifesciences Corp — Director's Dealing 2017

May 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2017-05-10

Reporting Person: Verguet Patrick B (CVP, Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-10	Common Stock	M	9625.0000	—	Acquired	138762.1496	Direct
2017-05-10	Common Stock	F	494.0000	$110.5800	Disposed	138268.1496	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-10	Performance Rights	$	M	9625.0000	Disposed	2017-05-31	Common Stock (9625.0000)	Direct

Footnotes

F1: On May 8, 2014, the Reporting Person was granted a target number of shares (5,500) covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 10, 2017, 175% of the target shares vested and were issued, and the actual number of shares vested are reflected on this Form.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.